AIP
RCUS icon

Ameritas Investment Partners’s Arcus Biosciences RCUS Stock Holding History

Ameritas Investment Partners’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Buy
6,865
+481
+8% +$10.4K ﹤0.01% 1441
2025
Q4 		$152K Buy
6,384
+625
+11% +$12.8K ﹤0.01% 1432
2025
Q3 		$78.3K Sell
5,759
-1,279
-18% -$13.3K ﹤0.01% 1842
2025
Q2 		$57.3K Buy
7,038
+1,796
+34% +$15.3K ﹤0.01% 2100
2025
Q1 		$41.1K Hold
5,242
– – ﹤0.01% 2222
2024
Q4 		$78.1K Hold
5,242
– – ﹤0.01% 1928
2024
Q3 		$80.2K Hold
5,242
– – ﹤0.01% 1923
2024
Q2 		$79.8K Hold
5,242
– – ﹤0.01% 1870
2024
Q1 		$99K Hold
5,242
– – ﹤0.01% 1749
2023
Q4 		$100K Hold
5,242
– – ﹤0.01% 1730
2023
Q3 		$94.1K Buy
5,242
+886
+20% +$17.8K ﹤0.01% 1704
2023
Q2 		$88.5K Buy
4,356
+459
+12% +$8.74K ﹤0.01% 1686
2023
Q1 		$71.1K Hold
3,897
– – ﹤0.01% 1761
2022
Q4 		$85.8K Hold
3,897
– – ﹤0.01% 1708
2022
Q3 		$101K Buy
3,897
+305
+8% +$8.07K ﹤0.01% 1482
2022
Q2 		$91K Hold
3,592
– – ﹤0.01% 1583
2022
Q1 		$113K Hold
3,592
– – ﹤0.01% 1562
2021
Q4 		$145K Hold
3,592
– – ﹤0.01% 1450
2021
Q3 		$125K Hold
3,592
– – ﹤0.01% 1554
2021
Q2 		$99K Hold
3,592
– – ﹤0.01% 1727
2021
Q1 		$101K Hold
3,592
– – ﹤0.01% 1666
2020
Q4 		$93K Hold
3,592
– – ﹤0.01% 1625
2020
Q3 		$62K Buy
3,592
+760
+27% +$17K ﹤0.01% 1707
2020
Q2 		$70K Buy
2,832
+300
+12% +$8.1K ﹤0.01% 1628
2020
Q1 		$35K Hold
2,532
– – ﹤0.01% 1862
2019
Q4 		$26K Hold
2,532
– – ﹤0.01% 2282
2019
Q3 		$23K Hold
2,532
– – ﹤0.01% 2319
2019
Q2 		$20K Hold
2,532
– – ﹤0.01% 2444
2019
Q1 		$32K Hold
2,532
– – ﹤0.01% 2119
2018
Q4 		$27K Buy
2,532
+2,100
+486% +$24.5K ﹤0.01% 2163
2018
Q3 		$6K Hold
432
– – ﹤0.01% 2931
2018
Q2 		$5K Buy
+432
New +$6.78K ﹤0.01% 2942

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Ameritas Investment Partners's RCUS Position: Q1 2026 in Review

Ameritas Investment Partners increased its Arcus Biosciences (RCUS) stake by 7.5% in Q1 2026, buying an estimated $10.4K and bringing the position to 6,865 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

Ameritas Investment Partners first reported a position in RCUS in Q2 2018 and has held it in 32 quarters since. The position peaked at $152K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Ameritas Investment Partners held 6,865 shares of Arcus Biosciences worth $148K as of Q1 2026.
  • Ameritas Investment Partners bought 481 Arcus Biosciences shares in Q1 2026, an estimated $10.4K.
  • Arcus Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1441 holding.
  • Ameritas Investment Partners first reported a position in Arcus Biosciences in Q2 2018 and has held it in 32 quarters since.
  • Ameritas Investment Partners's Arcus Biosciences position peaked at $152K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.